Portfolio company
AtoCap
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops biodegradable microcapsules for targeted drug delivery to treat recurrent infections and bladder cancer for pharmaceutical partners and clinical providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioTryp
This company develops oral antibiofilm therapies to treat bacterial infections for patients, primarily focusing on individuals with urinary tract infections.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
BioSapien
This company develops 3D-printed biodegradable mesh for localized and sustained delivery of chemotherapy drugs to cancer patients.
BLEED DETECTION SYSTEM
This company develops an ingestible sensor capsule and receiver to detect upper gastrointestinal bleeding for healthcare providers treating adult patients.
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
